Sign Up Today and Learn More About Attovia Therapeutics Stock
Invest in or calculate the value of your shares in Attovia Therapeutics or other pre-IPO companies through EquityZen's platform.
Attovia Therapeutics Stock (ATTH)
Attovia Therapeutics develops a pipeline of biotherapeutics for immune-mediated diseases.
About Attovia Therapeutics Stock
Founded
2023
Headquarters
Fremont, CA, US
Industries
Science and Engineering, Health Care, Biotechnology
Attovia Therapeutics Press Mentions
Stay in the know about the latest news on Attovia Therapeutics
Attovia Secures $105M Series B to Expand I&I Pipeline of Bispecific Antibodies
biospace • Aug 03, 2024
Attovia Therapeutics Announces Election of Mitchell Gold and Angie You to Board of Directors
finance • Aug 03, 2024
Attovia Announces Second Tranche Closing of $60 Million
globenewswire • Jul 24, 2024
Attovia Therapeutics Announces Election of Mitchell Gold and Angie You to Board of Directors
globenewswire • Jul 24, 2024
Attovia raises $105 million
thepharmaletter • Jun 04, 2024
Attovia Therapeutics Management
Leadership team at Attovia Therapeutics
Chief Executive Officer and Founder
Tao Fu
Board Member
Colin Walsh
Join now and verify your accreditation status to gain access to:
- Attovia Therapeutics current valuation
- Attovia Therapeutics stock price
- Available deals in Attovia Therapeutics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Attovia Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Attovia Therapeutics through EquityZen funds. These investments are made available by existing Attovia Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Attovia Therapeutics stock?
Shareholders can sell their Attovia Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 320K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."